应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EYPT EyePoint
休市中 08-23 16:00:00 EDT
9.19
+0.19
+2.11%
盘后
9.19
+0.00
0.00%
19:18 EDT
最高
9.59
最低
9.00
成交量
66.55万
今开
9.02
昨收
9.00
日振幅
6.61%
总市值
4.92亿
流通市值
3.30亿
总股本
5,352万
成交额
618.57万
换手率
1.85%
流通股本
3,588万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Eyepoint Pharmaceuticals, Inc.盘中异动 快速上涨5.00%报9.45美元
市场透视 · 08-23 22:28
Eyepoint Pharmaceuticals, Inc.盘中异动 快速上涨5.00%报9.45美元
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.18%报8.12美元
市场透视 · 08-21
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.18%报8.12美元
贝达药业:目前,EYP-1901项目在美国预计于下半年开展III期临床试验
每日经济新闻 · 08-16
贝达药业:目前,EYP-1901项目在美国预计于下半年开展III期临床试验
Eyepoint Pharmaceuticals, Inc.2024财年第二财季实现净利润-30.83百万美元,同比减少34.51%
自选股智能写手 · 08-16
Eyepoint Pharmaceuticals, Inc.2024财年第二财季实现净利润-30.83百万美元,同比减少34.51%
Eyepoint Pharmaceuticals, Inc.盘中异动 急速拉升5.13%
自选股智能写手 · 08-15
Eyepoint Pharmaceuticals, Inc.盘中异动 急速拉升5.13%
Eyepoint Pharmaceuticals, Inc.盘中异动 快速下跌5.10%报7.45美元
自选股智能写手 · 08-14
Eyepoint Pharmaceuticals, Inc.盘中异动 快速下跌5.10%报7.45美元
Eyepoint Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.14%
自选股智能写手 · 08-14
Eyepoint Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.14%
美国研究综述-阿波罗、黑石、好时
Reuters · 08-13
美国研究综述-阿波罗、黑石、好时
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.35%报8.67美元
自选股智能写手 · 08-09
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.35%报8.67美元
EyePoint Pharmaceuticals Inc 报告截至一月的季度业绩 - 收益摘要
Reuters · 08-09
EyePoint Pharmaceuticals Inc 报告截至一月的季度业绩 - 收益摘要
Eyepoint Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.09美元
自选股智能写手 · 08-08
Eyepoint Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.09美元
EyePoint Pharmaceuticals Inc 预计每股亏损 57 美分 - 财报前瞻
Reuters · 08-07
EyePoint Pharmaceuticals Inc 预计每股亏损 57 美分 - 财报前瞻
Eyepoint Pharmaceuticals, Inc.盘中异动 快速拉升5.18%
自选股智能写手 · 08-07
Eyepoint Pharmaceuticals, Inc.盘中异动 快速拉升5.18%
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报8.65美元
自选股智能写手 · 08-02
Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报8.65美元
Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报9.37美元
自选股智能写手 · 08-01
Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报9.37美元
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅上涨5.08%
自选股智能写手 · 07-25
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅上涨5.08%
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.22%
自选股智能写手 · 07-18
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.22%
【贝达药业(300558.SZ):EYP-1901玻璃体内植入剂药物获得临床试验批准】智通财经APP讯, 贝达药业(300558.
智通财经 · 07-15
【贝达药业(300558.SZ):EYP-1901玻璃体内植入剂药物获得临床试验批准】智通财经APP讯, 贝达药业(300558.
Eyepoint Pharmaceuticals, Inc.盘中异动 急速下挫5.05%
自选股智能写手 · 07-03
Eyepoint Pharmaceuticals, Inc.盘中异动 急速下挫5.05%
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅下跌5.17%
自选股智能写手 · 07-01
Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅下跌5.17%
加载更多
公司概况
公司名称:
EyePoint
所属市场:
NASDAQ
上市日期:
--
主营业务:
EyePoint Pharmaceuticals Inc.于2008年3月成为特拉华州公司。其前身,pSivida有限公司于2000年12月在西澳大利亚注册成立一家澳大利亚公司。 pSivida开发微小,缓释,药物输送的产品。该公司用于药物输送的产品,依其设计,几个月或几年中都可控制和稳定输送药物速率。pSivida公司专注于利用其核心技术平台,Durasert和BioSilicon治疗眼睛后部的慢性疾病。 pSivida目前有三个认可的产品和两个主要正在开发的候选产品,这些产品代表了连续几代的Durasert技术平台。 pSivida公司开发的四分之三用于治疗视网膜疾病的缓释装置,目前已获得美国或欧洲联盟(欧盟)的批准。
发行价格:
--
{"stockData":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":9.19,"timestamp":1724443200000,"preClose":9,"halted":0,"volume":665533,"hourTrading":{"tag":"盘后","latestPrice":9.19,"preClose":9.19,"latestTime":"19:18 EDT","volume":138574,"amount":1273495,"timestamp":1724455132976},"delay":0,"floatShares":35878843,"shares":53518210,"eps":-1.860396,"marketStatus":"休市中","marketStatusCode":7,"change":0.19,"latestTime":"08-23 16:00:00 EDT","open":9.02,"high":9.59,"low":8.995,"amount":6185651.382306,"amplitude":0.066111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.860396,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":9,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.98,"preClose":9,"latestTime":"09:20 EDT","volume":1421,"amount":12859.980371,"timestamp":1724419226791},"postHourTrading":{"tag":"盘后","latestPrice":9.19,"preClose":9.19,"latestTime":"19:18 EDT","volume":138574,"amount":1273495,"timestamp":1724455132976},"volumeRatio":1.2170485134474565,"impliedVol":0.0929,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/EYPT","defaultTab":"news","newsList":[{"id":"2461553513","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速上涨5.00%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461553513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461553513?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:28","pubTimestamp":1724423326,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时28分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.00%。截至发稿,该股报9.45美元/股,成交量9.3702万股,换手率0.18%,振幅5.39%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。其相关个股中,Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Arcutis Biotherapeutics, Inc.涨幅较大,Portage Biotech Inc.、Elevai Labs, Inc.、Virax Biolabs Group Limited较为活跃,换手率分别为2694.05%、144.68%、137.26%,振幅较大的相关个股有Portage Biotech Inc.、Anew Medical Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025,振幅分别为162.20%、72.14%、32.97%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823222846ab5f6bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823222846ab5f6bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4585","LU0889565916.HKD","EYPT","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2461829211","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.18%报8.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461829211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461829211?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:34","pubTimestamp":1724247275,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日21时34分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.18%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Azitra Inc涨幅较大,Revelation Biosciences, Inc.、Bio-Path Holdings, Inc.、Galmed Pharmaceuticals Ltd.较为活跃,换手率分别为1028.38%、392.96%、173.46%,振幅较大的相关个股有Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Entero Therapeutics Inc.,振幅分别为50.07%、34.40%、33.09%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821213435ab5edcec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821213435ab5edcec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0109394709.USD","BK4588","BK4585","EYPT","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2459261344","title":"贝达药业:目前,EYP-1901项目在美国预计于下半年开展III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2459261344","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459261344?lang=zh_cn&edition=full","pubTime":"2024-08-16 15:31","pubTimestamp":1723793495,"startTime":"0","endTime":"0","summary":"贝达药业有没有参与此次增发股份,以进一步加强合作并加快推进合作项目进展?目前,EYP-1901项目在美国预计于下半年开展III期临床试验,其国内的wAMD适应症药物临床试验申请已于近期获批开展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816153224959dcdd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816153224959dcdd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4134","BK4588","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4007","EYPT","III","BK4585"],"gpt_icon":0},{"id":"2459778174","title":"Eyepoint Pharmaceuticals, Inc.2024财年第二财季实现净利润-30.83百万美元,同比减少34.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459778174","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459778174?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737759,"startTime":"0","endTime":"0","summary":"8月16日,Eyepoint Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-30.83百万美元,同比减少34.51%;其中营业收入为9.48百万美元,同比增加4.06%,每股基本收益为-0.58美元。从资产负债表来看,Eyepoint Pharmaceuticals, Inc.总负债95.94百万美元,其中短期债务1.13百万美元,资产负债比为0.04,流动比率为0.05。机构评级:截至2024年8月16日,当前有10家机构对Eyepoint Pharmaceuticals, Inc.目标价做出预测,其中目标均价为38.80美元,其中最低目标价为28.00美元,最高目标价为68.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002529f2e4482&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002529f2e4482&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT"],"gpt_icon":0},{"id":"2459476078","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476078","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476078?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:40","pubTimestamp":1723732847,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时40分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.13%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为6018.31%、1998.59%、515.15%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.,振幅分别为103.98%、79.83%、70.46%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815224047a1d47414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815224047a1d47414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LU0889565916.HKD","EYPT","LU0320765992.SGD","BK4007","LU0109394709.USD"],"gpt_icon":0},{"id":"2459101926","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速下跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459101926","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459101926?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:29","pubTimestamp":1723649347,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时29分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.10%。截至发稿,该股报7.45美元/股,成交量49.6996万股,换手率0.93%,振幅6.62%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Zura Bio Limited C/Wts 、Unicycive Therapeutics, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大,Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm Plc较为活跃,换手率分别为87.62%、74.85%、66.67%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm Plc,振幅分别为60.83%、58.52%、49.86%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814232907968263c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814232907968263c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4007","EYPT","BK4585"],"gpt_icon":0},{"id":"2459331391","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459331391","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459331391?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:17","pubTimestamp":1723573021,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日02时17分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.14%。截至发稿,该股报7.93美元/股,成交量52.4146万股,换手率0.98%,振幅8.13%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.50%。其相关个股中,Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Revolution Medicines Inc C/Wts 17/12/2026 、Orgenesis Inc.涨幅较大,Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃,换手率分别为146.49%、137.20%、40.03%,振幅较大的相关个股有冠科美博、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Os Therapies Incorporated,振幅分别为78.40%、49.54%、42.38%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814021701968260c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814021701968260c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0889565916.HKD","EYPT","LU0320765992.SGD","LU0109394709.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2459926585","title":"美国研究综述-阿波罗、黑石、好时","url":"https://stock-news.laohu8.com/highlight/detail?id=2459926585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459926585?lang=zh_cn&edition=full","pubTime":"2024-08-13 16:45","pubTimestamp":1723538737,"startTime":"0","endTime":"0","summary":" 路透8月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括阿波罗、黑石和好时。要闻 * 阿波罗 :杰富瑞将目标价从 129 美元下调至 114 美元 * Blackstone :杰富瑞将目标价从 138 美元上调至 147 美元 * 好时 :高盛给予卖出评级 * Palomar Holdings Inc :KBW将目标价从96美元上调至113美元 * 沃尔玛 :CFRA将目标价上调3美元至75美元 以下是路透周二报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","AIG","HSY","LU1366333091.USD","BX","THG","BVS","FTRE","DUK","ESPR","CWEN","GIS","HLT","AMCX","APLS","CMPX","CEG","BK4554","BK4535","CAG","BK4116","BK4533","ENV","AMPX","ARDT","DNMR","BOLD","DYN","CTKB","LU0175139822.USD","CMBM","ADVM","LU1917777945.USD","ALTG","GETY","EYPT","APO","CNNE","ROAD","DE","LU1720051017.SGD","LU1244550221.USD","LU2211817866.USD","AKYA","COMM","GH","AZEK","AKAM","ARES","AJG"],"gpt_icon":0},{"id":"2458151832","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.35%报8.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458151832","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458151832?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:36","pubTimestamp":1723217764,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日23时36分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.35%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.45%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Azitra Inc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为349.33%、83.40%、61.85%,振幅较大的相关个股有Azitra Inc、Cingulate Inc.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为90.93%、35.31%、31.35%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809233604968257ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809233604968257ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0109394709.USD","BK4007","EYPT","BK4585","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2458595966","title":"EyePoint Pharmaceuticals Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595966","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595966?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210294,"startTime":"0","endTime":"0","summary":" * EyePoint Pharmaceuticals Inc 报告,在截至一月份的季度调整后每股亏损58美分,高于去年同期的每股-61美分。11位分析师对该季度的平均预期是每股亏损52美分。华尔街预期为每股亏损-66 美分至-34 美分。* EyePoint Pharmaceuticals Inc 公布的本季度每股收益为亏损 58 美分。* 该公司的季度亏损额为 3,083 万美元。* EyePoint Pharmaceuticals Inc 本季度股价上涨了 5.3%,今年迄今为止亏损了 60.4%。华尔街对 EyePoint Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EyePoint Pharmaceuticals Inc 报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4585","EYPT","BK4588"],"gpt_icon":0},{"id":"2457945348","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457945348","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457945348?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:57","pubTimestamp":1723129051,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时57分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.09%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为3.08%。其相关个股中,Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃,换手率分别为330.47%、282.91%、177.59%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.,振幅分别为74.12%、54.41%、42.63%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080822573296825330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080822573296825330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","EYPT","BK4588","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2457840130","title":"EyePoint Pharmaceuticals Inc 预计每股亏损 57 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457840130","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457840130?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:41","pubTimestamp":1723041671,"startTime":"0","endTime":"0","summary":" * EyePoint Pharmaceuticals Inc 将于 8 月 7 日公布截至 0001 年 1 月 1 日的财报,预计该公司的季度收入将出现下降。* LSEG 的分析师平均预期 EyePoint Pharmaceuticals Inc 每股亏损 57 美分。* 华尔街对 EyePoint Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元,高于其最新收盘价 9.02 美元。8月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EyePoint Pharmaceuticals Inc 预计每股亏损 57 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2457418318","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457418318","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457418318?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037462,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.18%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,G1 Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大,Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃,换手率分别为253.44%、131.51%、41.89%,振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、Enanta Pharmaceuticals, Inc.,振幅分别为16.93%、13.78%、11.92%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213102af96688c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213102af96688c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LU0889565916.HKD","EYPT","LU0320765992.SGD","BK4007","LU0109394709.USD"],"gpt_icon":0},{"id":"2456818562","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报8.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456818562","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456818562?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605481,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.22%。截至发稿,该股报8.65美元/股,成交量9906股,换手率0.02%,振幅1.75%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大,Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为213.48%、40.51%、16.49%,振幅较大的相关个股有Nuvation Bio Inc.、Xencor, Inc.、Springworks Therapeutics, Inc.,振幅分别为9.01%、8.12%、6.86%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213121941fd891&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213121941fd891&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007","EYPT","BK4588"],"gpt_icon":0},{"id":"2456432937","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报9.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456432937","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456432937?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:10","pubTimestamp":1722525033,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时10分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价急速下跌5.16%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Dermata Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Immuneering Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为286.30%、198.55%、125.80%,振幅较大的相关个股有Immuneering Corporation、Windtree Therapeutics, Inc.、Dermata Therapeutics, Inc.,振幅分别为40.71%、40.35%、39.53%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231033af95645f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231033af95645f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0320765992.SGD","EYPT","BK4007","BK4585","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2454096518","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454096518","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454096518?lang=zh_cn&edition=full","pubTime":"2024-07-25 23:59","pubTimestamp":1721923165,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日23时59分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.08%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Viking Therapeutics, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃,换手率分别为3787.15%、528.17%、269.67%,振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.,振幅分别为141.72%、132.26%、98.60%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725235925aefb79da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725235925aefb79da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4585","EYPT","BK4588"],"gpt_icon":0},{"id":"2452439451","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439451","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452439451?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:51","pubTimestamp":1721317869,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时51分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价急速下挫5.22%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.99%。其相关个股中,Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为2233.93%、2044.39%、1178.09%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235109941f85fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235109941f85fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","EYPT","BK4588","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2451905416","title":"【贝达药业(300558.SZ):EYP-1901玻璃体内植入剂药物获得临床试验批准】智通财经APP讯, 贝达药业(300558.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451905416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451905416?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:52","pubTimestamp":1721029974,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","PSQ",".IXIC","MNQmain","BK4585","BK1576","BK4007","EYPT","LU0320765992.SGD","TQQQ","LU0889565916.HKD","QID","SQQQ","LU0109394709.USD","03347","QLD","QQQ","300558","BK4588","BK1141","BK0239","NQmain","BK0060"],"gpt_icon":0},{"id":"2448162556","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448162556","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448162556?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:48","pubTimestamp":1719938905,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时48分,Eyepoint Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.05%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。其相关个股中,Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Mustang Bio, Inc.、Annovis Bio, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为60.35%、56.60%、54.69%,振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为75.14%、72.83%、39.76%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070300482596818dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070300482596818dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4007","BK4588","BK4585"],"gpt_icon":0},{"id":"2448912990","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448912990","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448912990?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:34","pubTimestamp":1719848073,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时34分,Eyepoint Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.17%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Eyenovia, Inc.涨幅较大,Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为627.70%、172.30%、105.80%,振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为101.49%、67.19%、56.01%。Eyepoint Pharmaceuticals, Inc.公司简介:EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701233433941f2c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701233433941f2c85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EYPT","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eyepointpharma.com","stockEarnings":[{"period":"1week","weight":0.1589},{"period":"1month","weight":0.0033},{"period":"3month","weight":-0.1765},{"period":"6month","weight":-0.6538},{"period":"1year","weight":-0.2016},{"period":"ytd","weight":-0.6023}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"EyePoint Pharmaceuticals Inc.于2008年3月成为特拉华州公司。其前身,pSivida有限公司于2000年12月在西澳大利亚注册成立一家澳大利亚公司。 pSivida开发微小,缓释,药物输送的产品。该公司用于药物输送的产品,依其设计,几个月或几年中都可控制和稳定输送药物速率。pSivida公司专注于利用其核心技术平台,Durasert和BioSilicon治疗眼睛后部的慢性疾病。 pSivida目前有三个认可的产品和两个主要正在开发的候选产品,这些产品代表了连续几代的Durasert技术平台。 pSivida公司开发的四分之三用于治疗视网膜疾病的缓释装置,目前已获得美国或欧洲联盟(欧盟)的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.578947,"avgChangeRate":0.064874},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000798},{"month":3,"riseRate":0.4,"avgChangeRate":0.006089},{"month":4,"riseRate":0.5,"avgChangeRate":0.150438},{"month":5,"riseRate":0.35,"avgChangeRate":-0.002292},{"month":6,"riseRate":0.3,"avgChangeRate":-0.036354},{"month":7,"riseRate":0.6,"avgChangeRate":0.044635},{"month":8,"riseRate":0.3,"avgChangeRate":-0.033637},{"month":9,"riseRate":0.368421,"avgChangeRate":0.001753},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.073209},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.048837},{"month":12,"riseRate":0.368421,"avgChangeRate":0.125153}],"exchange":"NASDAQ","name":"EyePoint","nameEN":"EyePoint"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"EyePoint,EYPT,EyePoint股票,EyePoint股票老虎,EyePoint股票老虎国际,EyePoint行情,EyePoint股票行情,EyePoint股价,EyePoint股市,EyePoint股票价格,EyePoint股票交易,EyePoint股票购买,EyePoint股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}